Bladder Cancer Clinical Trial

Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers

Summary

This study will test feasibility, in smokers with lung, head & neck, and bladder cancers, that examines the effect of e-cigarette substitution, on measures of smoking-related toxicity and medical outcomes. The aim of the study is to determine the appeal of e-cigarettes compared to regular combustible cigarettes.

View Full Description

Full Description

The aim of the study is to determine the appeal of e-cigarettes compared to combustible cigarettes as measured by the degree to which patients succeed in reducing their cigarette consumption over the 9 weeks they are supplied with product, along with their consumption of e-cigarettes. We will measure past use of e-cigarettes and cigarettes at baseline, 3, 6, 9, and 12 weeks. We will also assess the effect of e-cigarette substitution on toxicity by measuring expired carbon monoxide and urine NNAL (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) , a carcinogenic metabolite of cigarette smoke.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Histological or cytological diagnosis of lung, head & neck, or bladder cancer within the past 5 years.
AJCC (American Joint Committee on Cancer) stages I-IV
Daily Smoking (at least 10 cigarettes per day for 10 years) and breath CO (carbon monoxide) greater than or equal to 9 ppm
Does not wish to quit smoking now (anyone wishing to quit smoking will be referred for smoking cessation counselling through the DHMC (Dartmouth Hitchcock Medical Center) program)
May be receiving anti-cancer agents
Age 18 or older
Fluent in English;
Patient must be capable and willing to provide informed written consent for study participation;
Able to participate in study visits

Exclusion Criteria:

Cancer surgery planned in the next 9 weeks;
Treatment with radiation planned for the next 9 weeks,
Actively trying to quit smoking, or planning to in the next 30 days. (If a subject reports that they plan to quit smoking in the next 30 days, we will call them after the 30 days to see if they are still trying to quit.)
Any use of e-cigarettes in the past 30 days,
Pregnant or trying to get pregnant.

Study is for people with:

Bladder Cancer

Estimated Enrollment:

19

Study ID:

NCT02648178

Recruitment Status:

Completed

Sponsor:

Dartmouth-Hitchcock Medical Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Dartmouth Hitchcock Medical Center
Lebanon New Hampshire, 03756, United States

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Estimated Enrollment:

19

Study ID:

NCT02648178

Recruitment Status:

Completed

Sponsor:


Dartmouth-Hitchcock Medical Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider